Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 21, 2016 - Issue 1
Submit an article Journal homepage
5,707
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs and alternative possibilities in the treatment of tuberculosis

S. HofmanUniversity of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands
,
M.M. SegersUniversity of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands
,
S. GhimireUniversity of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands
,
M.S. BolhuisUniversity of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands
,
M.G.G. SturkenboomUniversity of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands
,
D. Van SoolingenDepartments of Pulmonary Diseases and Medical Microbiology, Nijmegen Medical Center, Radboud University, Nijmegen, The Netherlands;National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
&
J.W.C. AlffenaarUniversity of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the NetherlandsCorrespondence[email protected]
 show all
Pages 103-116 | Received 29 Nov 2015, Accepted 29 Jan 2016, Published online: 20 Feb 2016

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Juan Alberto Guevara Salazar, Jessica Rubí Morán Díaz, Enrique Ramírez Segura & José Guadalupe Trujillo Ferrara. (2021) What are the origins of growing microbial resistance? Both Lamarck and Darwin were right. Expert Review of Anti-infective Therapy 19:5, pages 563-569.
Read now
Jan-Willem C. Alffenaar, Onno W. Akkerman, Richard M. Anthony, Simon Tiberi, Scott Heysell, Martin P. Grobusch, Frank G. Cobelens & Dick Van Soolingen. (2017) Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers. Expert Review of Anti-infective Therapy 15:1, pages 11-21.
Read now

Articles from other publishers (10)

Ankit Verma, Bindu Naik, Vijay Kumar, Sadhna Mishra, Megha Choudhary, Javed Masood Khan, Arun Kumar Gupta, Piyush Pandey, Sarvesh Rustagi, Barnali Kakati & Sanjay Gupta. (2023) Revolutionizing Tuberculosis Treatment: Uncovering New Drugs and Breakthrough Inhibitors to Combat Drug-Resistant Mycobacterium tuberculosis . ACS Infectious Diseases 9:12, pages 2369-2385.
Crossref
Paola Santos, Milena Maya-Hoyos, Marcela López-R, Cristian Rosales, Vanessa Vásquez, Andrés Varón, Bibiana Chavarro-Portillo, Nelson Enrique Arenas & Carlos Y. Soto. 2023. Tuberculosis. Tuberculosis 459 481 .
Klaudia T. Angula, Lesetja J. Legoabe & Richard M. Beteck. (2021) Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010–2020 Review. Pharmaceuticals 14:5, pages 461.
Crossref
Bashir A. Sheikh, Basharat A. Bhat, Umar Mehraj, Wajahat Mir, Suhail Hamadani & Manzoor A. Mir. (2021) Development of New Therapeutics to Meet the Current Challenge of Drug Resistant Tuberculosis. Current Pharmaceutical Biotechnology 22:4, pages 480-500.
Crossref
Sandeep Kumar Marvadi, Vagolu Siva Krishna, Ekaterina O. Sinegubova, Alexandrina S. Volobueva, Yana L. Esaulkova, Anna A. Muryleva, Dmitry G. Tentler, Dharmarajan Sriram, Vladimir V. Zarubaev & Srinivas Kantevari. (2019) 5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation. Bioorganic & Medicinal Chemistry Letters 29:18, pages 2664-2669.
Crossref
Maria PuiuChristina Julius. (2019) Bacteriophage gene products as potential antimicrobials against tuberculosis. Biochemical Society Transactions 47:3, pages 847-860.
Crossref
Sandeep Kumar Marvadi, Vagolu Siva Krishna, Dharmarajan Sriram & Srinivas Kantevari. (2019) Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents. Bioorganic & Medicinal Chemistry Letters 29:4, pages 529-533.
Crossref
Natalja Genina, Johan Peter Boetker, Stefano Colombo, Necati Harmankaya, Jukka Rantanen & Adam Bohr. (2017) Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing. Journal of Controlled Release 268, pages 40-48.
Crossref
Zhonghua Liu, Yulu Gao, Hua Yang, Haiyang Bao, Lianhua Qin, Changtai Zhu, Yawen Chen & Zhongyi Hu. (2016) Impact of Hypoxia on Drug Resistance and Growth Characteristics of Mycobacterium tuberculosis Clinical Isolates. PLOS ONE 11:11, pages e0166052.
Crossref
Lokesh Pulipati, Jonnalagadda Padma Sridevi, Perumal Yogeeswari, Dharmarajan Sriram & Srinivas Kantevari. (2016) Synthesis and antitubercular evaluation of novel dibenzo[ b , d ]thiophene tethered imidazo[1,2- a ]pyridine-3-carboxamides. Bioorganic & Medicinal Chemistry Letters 26:13, pages 3135-3140.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.